======= UBE2V2 =======
== Gene Information ==
* **Official Symbol**: UBE2V2
* **Official Name**: ubiquitin conjugating enzyme E2 V2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7336|7336]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q15819|Q15819]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=UBE2V2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UBE2V2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603001|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through 'Lys-63'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage. {ECO:0000269|PubMed:10089880, ECO:0000269|PubMed:14562038, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:9705497}.
|UQ con|
|error-free postreplication DNA repair|
|UBC13-MMS2 complex|
|DNA double-strand break processing|
|protein K63-linked ubiquitination|
|ubiquitin conjugating enzyme activity|
|postreplication repair|
|double-strand break repair via nonhomologous end joining|
|non-recombinational repair|
|regulation of DNA repair|
|double-strand break repair|
|regulation of response to DNA damage stimulus|
|protein polyubiquitination|
|regulation of DNA metabolic process|
|DNA repair|
|protein ubiquitination|
|regulation of cellular response to stress|
|DNA metabolic process|
|protein modification by small protein conjugation|
|cellular response to DNA damage stimulus|
|protein modification by small protein conjugation or removal|
|regulation of response to stress|
|cellular response to stress|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.75|
|[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|1.96|
|[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|2.25|
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|2.29|
|[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.4|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18897
* **Expression level (log2 read counts)**: 6.08
{{:chemogenomics:nalm6 dist.png?nolink |}}